Ochsner Health COVID-19 SharePoint Site "Safety On Site" Click here to enter an S.O.S.
Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Search results for:

bendamustine

bendamustine
Drug Name Form Strength Infusion Center Available Restricted Non-formulary Ambulatory Available Interchange REMS
Treanda POWDER FOR INJECTION, INTRAVENOUS 25 mg; 100 mg          
Belrapzo SOLUTION, INTRAVENOUS 25 mg/mL          
Bendeka SOLUTION, INTRAVENOUS 25 mg/mL        
Treanda SOLUTION, INTRAVENOUS 90 mg/mL          
VIEW MORE Antineoplastic Agents
CLASS
100000
High Alert Drug : Policy
Additional Information and Links

For use in Oncology Inpatient and Infusion Centers

Belrapzo is indicated for CLL, indolent B-cell NHL refractory to retuximab.

Patients currently receiving Bendeka will continue on it. Belrapzo will be used for new patients only. 

OHS.PHARM.OS.052 Management of Medication Extravasation and Antidotes

Last updated: Nov. 30, 2021

This site is intended for the staff of Ochsner Health. While others may view accessible pages, Ochsner Health makes no warranty, express or implied, as to the use of this information outside of Ochsner Health.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved